Missed Nvidia? Buy Elon Musk’s “Silent Partner”

In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.

So please click here to see the details because a lot of people could get rich.

Mark A. Emalfarb net worth and biography

Mark Emalfarb Biography and Net Worth

CEO of Dyadic International

Mark A. Emalfarb is the founder of Dyadic. He has been a member of Dyadic’s board of directors since October 2004 and has served as its Chairman as well as President and Chief Executive Officer from October 2004 until April 2007 and from June 2008 until the present.

Since founding Dyadic in 1979, Mr. Emalfarb has successfully led and managed the evolution of Dyadic from its origins as a pioneer and leader in providing ingredients used in the stone-washing of blue jeans to the discovery, development, manufacturing and commercialization of specialty enzymes used in various industrial applications and the development of an integrated technology platform based on Dyadic’s patented and proprietary C1 fungal microorganism.

Mr. Emalfarb is an inventor of over 25 U.S. and foreign biotechnology patents and patent applications resulting from discoveries related to the Company’s patented and proprietary C1 fungus, and has been the architect behind its formation of several strategic research and development, manufacturing and marketing relationships with U.S. and international partners.

Mr. Emalfarb earned his B.A. degree from the University of Iowa in 1977.

How old is Mark A. Emalfarb?: Mr. Emalfarb is currently 68 years old. There are 2 older executives and no younger executives at Dyadic International. Learn More on Mark A. Emalfarb's age.
How do I contact Mark A. Emalfarb?: The corporate mailing address for Mr. Emalfarb and other Dyadic International executives is 140 INTRACOASTAL POINTE DRIVE SUITE 404, JUPITER FL, 33477. Dyadic International can also be reached via phone at (561) 743-8333 and via email at [email protected]. Learn More on Mark A. Emalfarb's contact information.
Has Mark A. Emalfarb been buying or selling shares of Dyadic International?: Mark A. Emalfarb has not been actively trading shares of Dyadic International during the last quarter. Most recently, Mark A. Emalfarb sold 28,767 shares of the business's stock in a transaction on Thursday, December 23rd. The shares were sold at an average price of $4.10, for a transaction totalling $117,944.70. Learn More on Mark A. Emalfarb's trading history.
Who are Dyadic International's active insiders?: Dyadic International's insider roster includes Mark Emalfarb (CEO), and Ping Rawson (CFO). Learn More on Dyadic International's active insiders.

Mark A. Emalfarb Insider Trading History at Dyadic International

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
12/23/2021	Sell	28,767	$4.10	$117,944.70
12/21/2021	Sell	26,486	$4.33	$114,684.38
6/9/2021	Sell	23,000	$3.72	$85,560.00
6/7/2021	Sell	44,000	$3.95	$173,800.00
6/4/2021	Sell	132,000	$3.85	$508,200.00
6/2/2021	Sell	76,349	$3.74	$285,545.26

Mark A. Emalfarb Buying and Selling Activity at Dyadic International

Dyadic International Company Overview

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial to demonstrate the safety in humans of a protein produced using the C1 platform. It has also developed the Dapibus thermophilic, a filamentous fungal-based microbial protein production platform to enable the development and large-scale manufacture of cost-effective proteins, metabolites, and other biologic products for use in non-pharmaceutical applications, including food, nutrition, and wellness. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; Joint Development Agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Today's Range

Now: $1.75

$1.72

$2.05

50 Day Range

MA: $1.37

$1.05

$1.97

2 Week Range

Now: $1.75

$0.93

$2.67

Volume

264,890 shs

Average Volume

54,911 shs

Market Capitalization

$51.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.89